GlassScriptPhysician profile
Jacob Robert Rickoll
NPI 1225665417
$2,695.16
in general payments reported to CMS, 2019-2025
17 companies · $413 in 2025
The $413 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $305 · 2022: $741 · 2023: $809 · 2024: $428 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,649.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $701.01 | 2021-2025 | Descovy, Yeztugo |
| Janssen Pharmaceuticals, INC | $632.66 | 2022-2025 | Spravato |
| Viiv Healthcare Company | $189.60 | 2025 | Dovato |
| Alkermes, INC. | $189.02 | 2022-2024 | Vivitrol |
| Theratechnologies INC. | $176.91 | 2022-2023 | Egrifta Sv |
| Amgen INC. | $137.66 | 2023 | Repatha, Otezla |
| Medtronic, INC. | $135.43 | 2022 | |
| Novo Nordisk INC | $123.46 | 2022 | |
| Jazz Pharmaceuticals INC. | $97.46 | 2021 | |
| Neurelis, INC. | $82.37 | 2021 | |
| Abbvie INC. | $62.84 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $52.42 | 2023-2024 | Delstrigo, Pifeltro, Dificid |
| Janssen Biotech, INC. | $43.35 | 2022-2023 | Symtuza |
| Emd Serono, INC. | $20.19 | 2024 | |
| Endo Pharmaceuticals INC. | $18.41 | 2024 | Aveed |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $17.88 | 2023 | Aptima |
| Indivior INC. | $14.49 | 2024 | Sublocade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Rickoll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.